Sildenafil and celecoxib interact to kill breast cancer cells
Breast cancer is the second most commonly diagnosed cancer among American women and is responsible for the second highest number of cancer-related deaths. Targeted therapeutic agents sildenafil, a phosphodiesterase type 5 inhibitor, and celecoxib, a cyclooxygenase-2 inhibitor, have been used individ...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
VCU Scholars Compass
2014
|
| Subjects: | |
| Online Access: | http://scholarscompass.vcu.edu/etd/3580 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=4586&context=etd |